Subscribe by email

Get the latest from BioInvent

* required

Email*
[Missing text /ecommerce/fill for en]Email Please correct your email address

Name*
Please enter your full name

Company name
[Missing text /ecommerce/fill for en]Company name


[Missing text /ecommerce/fill for en]Type of information


[Missing text /ecommerce/fill for en]Sites

 

BioInvent

BioInvent International AB, which is listed on the O list of the Stockholm Stock Exchange (SAX:BINV), develops therapeutic antibodies against diseases where there is a significant unmet medical need. Antibodies are a str...

View more


  CONTACT  
  • Sten Westerberg
  • Vice President Investor Relations
  • +46 (0)768 68 50 09
  • +46 (0)46-286 85 50
  •